140 related articles for article (PubMed ID: 29325469)
1. Current update of a thermosensitive liposomes composed of DPPC and Brij78.
Ho L; Bokharaei M; Li SD
J Drug Target; 2018; 26(5-6):407-419. PubMed ID: 29325469
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
[TBL] [Abstract][Full Text] [Related]
3. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
Tagami T; May JP; Ernsting MJ; Li SD
J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
[TBL] [Abstract][Full Text] [Related]
4. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
[TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
6. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes upon Mild Hyperthermia in C26 Tumor Bearing BALB/c Mice.
Alavizadeh SH; Gheybi F; Nikpoor AR; Badiee A; Golmohammadzadeh S; Jaafari MR
Mol Pharm; 2017 Mar; 14(3):712-721. PubMed ID: 28135098
[TBL] [Abstract][Full Text] [Related]
8. Size of thermosensitive liposomes influences content release.
Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH
J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921
[TBL] [Abstract][Full Text] [Related]
9. Inhomogeneous crystal grain formation in DPPC-DSPC based thermosensitive liposomes determines content release kinetics.
Lu T; Ten Hagen TLM
J Control Release; 2017 Feb; 247():64-72. PubMed ID: 28042084
[TBL] [Abstract][Full Text] [Related]
10. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
[TBL] [Abstract][Full Text] [Related]
11. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
[TBL] [Abstract][Full Text] [Related]
12. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration.
Tagami T; Kubota M; Ozeki T
J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors.
May JP; Ernsting MJ; Undzys E; Li SD
Mol Pharm; 2013 Dec; 10(12):4499-508. PubMed ID: 24152292
[TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M
Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721
[TBL] [Abstract][Full Text] [Related]
15. Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant.
Song H; Zhang J; Liu X; Deng T; Yao P; Zhou S; Yan W
Pharm Dev Technol; 2016 Sep; 21(6):680-7. PubMed ID: 25975585
[TBL] [Abstract][Full Text] [Related]
16. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
[TBL] [Abstract][Full Text] [Related]
17. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
18. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes.
Hossann M; Wiggenhorn M; Schwerdt A; Wachholz K; Teichert N; Eibl H; Issels RD; Lindner LH
Biochim Biophys Acta; 2007 Oct; 1768(10):2491-9. PubMed ID: 17618599
[TBL] [Abstract][Full Text] [Related]
19. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
20. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo.
Banno B; Ickenstein LM; Chiu GN; Bally MB; Thewalt J; Brief E; Wasan EK
J Pharm Sci; 2010 May; 99(5):2295-308. PubMed ID: 19902527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
